Analysis of clinicopathological features revealed that elevated SLC31A1 expression significantly correlated with poor differentiation, advanced TNM stage, extrathyroidal extension, and lymph node involvement, suggesting its role in tumor aggressiveness and metastatic potential. This evidence concerns the gene SLC31A1 and neoplasm.